Asian markets showed mixed results on Thursday, with commodities like Crude Oil WTI, Gold, Silver, and Copper trading lower amid economic concerns.

Stellantis shares lower premarket on Thursday. The company confirmed 2024 financial guidance and capital return plan of ≥€7.7 billion.

Vivani Medical cleared FDA for NPM-119 trial in type 2 diabetes. LIBERATE-1 will assess safety, tolerability, & pharmacokinetics. NPM-115 & NPM-139 also in development for weight management.

Boeing reportedly maintains it adhered to a 2021 agreement aimed at avoiding prosecution after the 737 MAX incidents, countering U.S. claims of non-compliance. The company's commitment to transparent engagement highlights its efforts to navigate legal complexities ahead of the Justice Department's crucial July 7 decision on extending prosecution terms.